6:17 PM
 | 
Jan 17, 2014
 |  BC Extra  |  Financial News

TaiGen raises $35.7 million in Taiwanese IPO

TaiGen Biopharmaceuticals Holdings Ltd. (GreTai:4157), the parent company of TaiGen Biotechnology Co. Ltd., raised NT$1.1 billion ($35.7 million) through the sale of 22 million shares at NT$50 in an IPO on the GreTai Securities Market. The price values the...

Read the full 178 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >